Natural History Study - Mitochondrial Disease
Part of paid clinical trials in New York, New York.
- Sponsor
- Columbia University
- Study ID
- NCT01532791
- Status
- Recruiting
Conditions
- MELAS or m.3243 A>G Mitochondrial DNA Mutation Carrier
Eligibility Criteria
- Sex
- ALL
- Age
- 4 Years - N/A
- Healthy Volunteers
- Accepted
Study Details
Carriers of the m.3242A\>G mutation often have clinical symptoms which can include migraines, seizures, strokes, hearing loss, balance issues, gastrointestinal issues, and many other symptoms. The investigators would like to learn more about these disorders and have designed a "Natural History Study" to monitor these conditions over time so that physicians and scientists can not only understand the problems that patients have, but work on developing treatments. The focus of the current work is to evaluate known mutation carriers of the m.3243A\>G (mitochondrial DNA) and their maternal relatives (carrier status not a requirement for participation). Paternal relatives will serve as controls. This study involves no treatment.
Key Dates
- Start date
- Jul 31, 2004
- Status verified
- Jan 2026
- Primary completion
- Jul 31, 2026
- Completion
- Jul 31, 2026
Study Design
- Enrollment
- 300 participants (estimated)
Arms
- Arm: mtDNA mutationm.3243 A\>G carriers and their maternal relatives Other mutations in the mitochondrial genome may be included
- Arm: Controlcontrols (people not maternally related to mutation carriers) Preference is for married in relatives
Primary Outcome Measure
MRI/MRS [ Time Frame: 2-3 years ]
Central Contacts
- Kris Engelstad, MS2123056834
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Columbia University | New York | New York | 10032 |